| # | Drug | Count |
|---|---|---|
| 0 | SPIRONOLACTONE | 14 |
| 1 | ETOPOSIDE | 13 |
| 2 | FUROSEMIDE | 13 |
| 3 | CARBOPLATIN | 11 |
| 4 | DEXAMETHASONE | 9 |
| 5 | DEXAMETHASONE 1.5 MG | 9 |
| 6 | GLIMEPIRIDE | 8 |
| 7 | PREDNISOLONE | 8 |
| 8 | PREDNISOLONE ORAL | 8 |
| 9 | PREDNISOLONE ORAL SOLUTION | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METYRAPONE | 4 | 0.0040 |
| 1 | ACETAZOLAMIDE SODIUM | 4 | 0.0007 |
| 2 | FLUVOXAMINE MALEATE | 1 | 0.0004 |
| 3 | INSULIN GLARGINE-YFGN | 7 | 0.0003 |
| 4 | GLIMEPIRIDE | 8 | 0.0002 |
| 5 | BICALUTAMIDE | 3 | 0.0002 |
| 6 | ETOPOSIDE | 13 | 0.0002 |
| 7 | ERLOTINIB HYDROCHLORIDE | 2 | 0.0002 |
| 8 | LANREOTIDE ACETATE | 1 | 0.0001 |
| 9 | ISONIAZID | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 16 |
| 1 | Aldosterone Antagonist [EPC] | 14 |
| 2 | Corticosteroid [EPC] | 14 |
| 3 | Loop Diuretic [EPC] | 13 |
| 4 | Topoisomerase Inhibitor [EPC] | 13 |
| 5 | Sulfonylurea [EPC] | 8 |
| 6 | Insulin Analog [EPC] | 7 |
| 7 | Osmotic Laxative [EPC] | 7 |
| 8 | Potassium Salt [EPC] | 7 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 4 | 0.0040 |
| 1 | Carbonic Anhydrase Inhibitor [EPC] | 4 | 0.0002 |
| 2 | Topoisomerase Inhibitor [EPC] | 13 | 0.0002 |
| 3 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 5 | Aldosterone Antagonist [EPC] | 14 | 0.0001 |
| 6 | Antimycobacterial [EPC] | 2 | 0.0001 |
| 7 | Sulfonylurea [EPC] | 8 | 0.0001 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 2 | 0.0001 |
| 9 | Glycopeptide Antibacterial [EPC] | 4 | 0.0001 |